Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
A | 0.800 | GeneticVariation | GWASCAT | Genome-wide meta-analysis identifies BARX1 and EML4-MTA3 as new loci associated with infantile hypertrophic pyloric stenosis. | 30281099 | 2019 | ||||||
|
|
|
A | 0.800 | GeneticVariation | GWASDB | Plasma lipids, genetic variants near APOA1, and the risk of infantile hypertrophic pyloric stenosis. | 23989729 | 2013 | ||||||
|
|
|
A | 0.800 | GeneticVariation | GWASCAT | Plasma lipids, genetic variants near APOA1, and the risk of infantile hypertrophic pyloric stenosis. | 23989729 | 2013 | ||||||
|
|
|
0.800 | GeneticVariation | UNIPROT | Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26. | 8208902 | 1994 | |||||||
|
|
|
0.800 | GeneticVariation | UNIPROT | Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. | 1502149 | 1992 | |||||||
|
|
|
0.800 | GeneticVariation | UNIPROT | A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. | 2123470 | 1990 | |||||||
|
|
|
0.800 | GeneticVariation | UNIPROT | Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. | 3142462 | 1988 | |||||||
|
|
|
C | 0.800 | CausalMutation | CLINVAR | |||||||||
|
|
|
0.700 | GeneticVariation | GWASCAT | Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. | 29403010 | 2018 | |||||||
|
|
|
T | 0.700 | GeneticVariation | GWASCAT | Genomic atlas of the human plasma proteome. | 29875488 | 2018 | ||||||
|
|
|
A | 0.700 | GeneticVariation | GWASCAT | Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation. | 27841878 | 2017 | ||||||
|
|
|
A | 0.700 | GeneticVariation | GWASCAT | Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation. | 27841878 | 2017 | ||||||
|
|
|
0.700 | GeneticVariation | GWASDB | Genome-wide association study identifies multiple loci influencing human serum metabolite levels. | 22286219 | 2012 | |||||||
|
|
|
0.700 | GeneticVariation | GWASDB | Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. | 23063622 | 2012 | |||||||
|
|
|
0.700 | GeneticVariation | GWASDB | Genome-wide association study identifies multiple loci influencing human serum metabolite levels. | 22286219 | 2012 | |||||||
|
|
|
0.700 | GeneticVariation | GWASDB | Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. | 23063622 | 2012 | |||||||
|
|
|
0.700 | GeneticVariation | UNIPROT | Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26. | 8208902 | 1994 | |||||||
|
|
|
0.700 | GeneticVariation | UNIPROT | Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. | 1502149 | 1992 | |||||||
|
|
|
0.700 | GeneticVariation | UNIPROT | A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. | 2123470 | 1990 | |||||||
|
|
|
0.700 | GeneticVariation | UNIPROT | Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. | 3142462 | 1988 | |||||||
|
|
|
A | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
T | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
T | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
C | 0.700 | CausalMutation | CLINVAR | |||||||||
|
|
|
C | 0.700 | CausalMutation | CLINVAR |